Official UK procurement notice
Reagents, Consumables & Servicing
Authority: NHS Grampian (NHS & healthcare)
What is being bought
Published requirement descriptionReagents & consumables and equipment are used for many testing pathways within the laboratory including regional patients for urgent cancer services such as lung, colorectal and haematological malignancies and rare disease disorders such Cystic Fibrosis
CPV: Laboratory reagents · Medical consumables · Repair and maintenance services of medical and precision equipment
The lotProcurement structure
single lot · no lot value publishedLot #1Award to existing supplier via waiverAwarded
Award to existing supplier via waiver.
These workstreams include Next Generation Sequencing, Microarray, PCR, Sanger sequencing and fragment analysis, and have all undergone extensive validation processes within the laboratory and are UKAS accredited.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 27 Feb 2026, 16:10 GMT
- Last source update
- 27 Feb 2026, 16:10 GMT
- Authority reference
NCT086-25- FTS notice number
2026/S 000-018114- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-065ec6Find a Tender
- Why no open competition
The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons
- Published justification
Purchase of alternative instruments and associated reagents & consumables would incur significant costs and involve delay to testing as additional extensive validation work would need to be undertaken before use.
Publisher note: (SC Ref:825113)
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Life Technologies Ltd | £912,780 † | — | Awarded |
Contracts
Contract 018114-2026-NCT086-25-1 · Life Technologies Ltd
- Signed
- 18 Feb 2026
- Value
- £912,780
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids · 1 electronic · 1 from abroad | 0 | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Aberdeen Sheriff CourtReview body
Bidders & participating suppliers
1 commercial party on the notice- Life Technologies LtdAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.